CHAPEL HILL, N.C., June 17 /PRNewswire/ -- Coordinating and timing
activities is a top challenge that many pharmaceutical companies face when
communicating the results of landmark clinical trials. Best-in-class
companies understand that successfully communicating results of a landmark
trial begins long before significant findings are available. Successful
communication depends on early actions across the board:
-- Early identification of breakthrough molecules in development
-- Early creation of potential product positioning
-- Early involvement of marketing to build commercial endpoints into the
-- Early scenario planning for different study results
Best Practices, LLC has benchmarked the efforts of world-class pharmaceutical companies in the development and execution of strategies for communicating clinical trial results.
For more information, download Best Practices, LLC's white paper on Communicating Clinical Study Results for Maximum Impact by clicking on the following link http://www.best-in-class.com/cr220.htm or contact Cameron Tew, Sr. Manager Research and Publishing at (919) 403-0251, ext. 246 or firstname.lastname@example.org .
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call (919) 403-0251 or visit http://www.best-in-class.com .
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved